Washington, D.C.— The DIVERSE Trials Act, introduced in both the House and Senate would increase diversity in clinical trials and make it easier for all cancer patients to participate in clinical trials. The bipartisan bicameral legislation, sponsored by Sens. Robert Menendez (D-N.J.) and Tim Scott (R-S.C.), and Reps. Raul